Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis. (October 2019)
- Record Type:
- Journal Article
- Title:
- Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis. (October 2019)
- Main Title:
- Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis
- Authors:
- Huang, Chun-Ta
Lee, Meng-Rui
Ruan, Sheng-Yuan
Tsai, Yi-Ju
Wang, Jann-Yuan
Yu, Chong-Jen - Abstract:
- Abstract: Background: _ The mitogen response in interferon-γ(IFN-γ) release assays(IGRAs) measures IFN-γ after binding to CD2, a surface adhesion marker found on T-cells and NK cells. A lower mitogen response implies either peripheral blood mononuclear cells have fewer adhesion molecules either in absolute numbers or per T-cells, or the pathway from adhesion molecules to IFN-γ production is not functioning well. To date, it remains poorly understood whether the mitogen response is associated with outcomes in tuberculosis patients. Methods: _ From 2012 to 2017, patients with culture-confirmed tuberculosis were tested for QuantiFERON-TB Gold In-Tube(QFT-GIT). The associations between patient outcomes and QFT-GIT as well as IFN-γ responses to the mitogen were investigated. Outcomes of interest included 1-year mortality after tuberculosis diagnosis and 2-month culture conversion. Results: _ In total, 466 culture-confirmed tuberculosis patients were enrolled and QFT-GIT was positive in 309(66%). Within 1 year of diagnosis, 20(4%) died and notably, 15(11%) out of 137 patients with a lower mitogen response did so. The multivariate Cox model showed that a lower mitogen response (hazard ratio, 8.789; 95% confidence interval, 3.074–25.129) was independently associated with 1-year mortality. Moreover, among 160 patients with smear-positive culture-confirmed pulmonary tuberculosis, multivariate logistic analysis indicated that a lower mitogen response (odds ratio, 3.966; 95% confidenceAbstract: Background: _ The mitogen response in interferon-γ(IFN-γ) release assays(IGRAs) measures IFN-γ after binding to CD2, a surface adhesion marker found on T-cells and NK cells. A lower mitogen response implies either peripheral blood mononuclear cells have fewer adhesion molecules either in absolute numbers or per T-cells, or the pathway from adhesion molecules to IFN-γ production is not functioning well. To date, it remains poorly understood whether the mitogen response is associated with outcomes in tuberculosis patients. Methods: _ From 2012 to 2017, patients with culture-confirmed tuberculosis were tested for QuantiFERON-TB Gold In-Tube(QFT-GIT). The associations between patient outcomes and QFT-GIT as well as IFN-γ responses to the mitogen were investigated. Outcomes of interest included 1-year mortality after tuberculosis diagnosis and 2-month culture conversion. Results: _ In total, 466 culture-confirmed tuberculosis patients were enrolled and QFT-GIT was positive in 309(66%). Within 1 year of diagnosis, 20(4%) died and notably, 15(11%) out of 137 patients with a lower mitogen response did so. The multivariate Cox model showed that a lower mitogen response (hazard ratio, 8.789; 95% confidence interval, 3.074–25.129) was independently associated with 1-year mortality. Moreover, among 160 patients with smear-positive culture-confirmed pulmonary tuberculosis, multivariate logistic analysis indicated that a lower mitogen response (odds ratio, 3.966; 95% confidence interval, 1.182–13.303) was significantly associated with 2-month culture persistence. Conclusions: _ This study found that a lower mitogen response was associated with worse 1-year survival in tuberculosis patients and correlated with 2-month culture persistence in patients with sputum smear-positive culture-confirmed tuberculosis. These findings suggest another application of QFT-GIT for prognostication of tuberculosis patients. Highlights: About two-thirds of culture-confirmed TB patients were tested positive for the QFT-GIT assay. A lower Mitogen response was significantly associated with a higher hazard of 1-year mortality in TB patients. Culture persistence at 2 months was more likely observed in smear-positive pulmonary TB patients with lower Mitogen response. … (more)
- Is Part Of:
- Respiratory medicine. Volume 158(2019)
- Journal:
- Respiratory medicine
- Issue:
- Volume 158(2019)
- Issue Display:
- Volume 158, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 158
- Issue:
- 2019
- Issue Sort Value:
- 2019-0158-2019-0000
- Page Start:
- 49
- Page End:
- 54
- Publication Date:
- 2019-10
- Subjects:
- Interferon-γ -- Interferon-γ release assay -- Mortality -- Prognosis -- Tuberculosis
Chest -- Diseases -- Periodicals
Chest -- Diseases -- Great Britain -- Periodicals
Respiratory organs -- Diseases -- Periodicals
Respiratory Tract Diseases -- Periodicals
Appareil respiratoire -- Maladies -- Périodiques
Thorax -- Maladies -- Périodiques
Appareil respiratoire -- Maladies -- Traitement -- Périodiques
Electronic journals
616.2 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09546111 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09546111 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09546111 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.rmed.2019.10.004 ↗
- Languages:
- English
- ISSNs:
- 0954-6111
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7777.661900
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26776.xml